Cystic Fibrosis (CF) is a progressive, genetic disease of secretory glands affecting approximately 30,000 people in the United States. The life expectancy of CF patients has risen due to treatment advances, making preconception and contraceptive counseling essential. Pregnancy is high risk in this population and dramatically impacts overall health. Additionally, some CF medications are teratogenic or reduce the efficacy of hormonal contraception. Barriers preventing adequate sexual and reproductive health counseling include lack of time, knowledge, and discomfort with the subject. We sought to evaluate counseling received and contraceptive use in female adolescent CF patients at our institution.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Journal of Pediatric and Adolescent Gynecology
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect